|
Federal Register Search Results
CDER - November 2004
Federal Register, Volume 69 (2004)
11/1/04
Total Hits: 1
-
[1] fr01no04N Draft Guidance
for Industry on Pharmacokinetics in Pregnancy--- Size: 6608 , Score: 867 , HTML
11/2/04
Total Hits: 2
-
[1] fr02no04N Determination of
Regulatory Review Period for Purposes of Patent- Size: 7083 , Score: 708 , HTML
-
[2] fr02no04P Cold, Cough, Allergy,
Bronchodilator, and Antiasthmatic Drug- Size: 49420 , Score: 444 , HTML
11/3/04
Total Hits: 0
11/4/04
Total Hits: 1
-
[1] fr04no04N Draft Guidance
for Industry on Listed Drugs, 30-Month Stays, and- Size: 8386 , Score: 831 , HTML
11/5/04
Total Hits: 0
11/8/04
Total Hits: 0
11/9/04
Total Hits: 0
11/10/04
Total Hits: 1
-
[1] fr10no04N Advisory Committees;
Filing of Annual Reports- Size: 2767 , Score: 982 , HTML
11/11/04
Total Hits: 0
11/12/04
Total Hits: 0
11/15/04
Total Hits: 0
11/16/04
Total Hits: 1
-
[1] fr16no04N Determination That
DYCLONE (Dyclonine Hydrochloride) 0.5% and- Size: 5428 , Score: 591 , HTML
11/17/04
Total Hits: 0
11/18/04
Total Hits: 1
-
[1] fr18no04N Oncologic Drugs
Advisory Committee; Notice of Meeting- Size: 3679 , Score: 632 , HTML
11/19/04
Total Hits: 1
-
[1] fr19no04N Guidance for Industry
on Continuous Marketing Applications: Pilot- Size: 6565 , Score: 1000 , HTML
11/22/04
Total Hits: 1
-
[1] fr22no04N Guidance for Industry on Changes to
an Approved New Drug
- Size: 6089 , Score: 940
, HTML
11/23/04
Total Hits: 0
11/24/04
Total Hits: 0
11/25/04
Total Hits: 0
11/26/04
Total Hits: 0
11/29/04
Total Hits: 3
-
[1] fr29no04N Draft Guidance for Industry on the Role
of Human Immunodeficiency
- Size: 6315 , Score: 939
, HTML
- [2] fr29no04N Determination That 7.5% and 8.4% Sodium
Bicarbonate Injection in
- Size: 5204 , Score: 654
, HTML
- [3] fr29no04R Drug Labeling; Sodium Labeling for Over-the-Counter
Drugs
- Size: 11620 , Score: 585
, HTML
11/30/04
Total Hits: 0
© 1997-2006 Betterchem
Corp.
|